On March 7, the National Molecular Drug Innovation Center (hereinafter referred to as "National Innovation Center") construction promotion and scheme demonstration meeting was held in Shenzhen Yinxing Science and Technology Park. Gan Xiaobin, deputy director of the Science and Technology Department of the Ministry of Industry and Information Technology, Wang Rui, director of the Technical Foundation Department of the Science and Technology Department, and relevant leaders of the Guangdong Provincial Department of Industry and Information Technology and Shenzhen attended the meeting.JOINN participated in the meeting as a shareholder and participating unit of the National Innovation Center.

Fan Shujian, former deputy director of the Science and Technology Department of the Ministry of Industry and Information Technology and first-class inspector, and experts from Jinan University, Shenyang Pharmaceutical University, Shenzhen Bay Laboratory and other scientific research institutes demonstrated and guided the construction plan of the National Innovation Center.

The National Innovation Center was approved by the Ministry of Industry and Information Technology in December 2024 and is the only national manufacturing innovation center in the field of molecular drugs. National Innovation Center to the molecular drug industry innovation and development of major demand for traction, integration of the industry's basic research, applied basic research, transformation research, quality research, manufacturing and industrialization of innovation resources,For key areas such as chemical drugs, biological drugs and high-end preparations, we will build four key common technology research and development platforms, including drug concept verification, microecology, high-end preparations and biotechnology drugs, as well as three public service platforms, including intellectual property rights, personnel training and achievement transformation, in order to promote the application of green pharmaceuticals and sustainable production process technologies,Promote the overall competitiveness of China's pharmaceutical industry.

As a participating unit of the National Innovation Center, JOINN undertakes the construction of the new drug evaluation sub-platform of the drug concept verification platform. Under the unified deployment and requirements of the National Innovation Center, JOINN will complete the task of building a new drug evaluation sub-platform with high quality and contribute to the National Innovation Center's service to China's pharmaceutical innovation.